BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
90 results:

  • 1. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
    Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma-A Systematic Review.
    Devi P; Dwivedi R; Sankar R; Jain A; Gupta S; Gupta S
    Head Neck Pathol; 2024 Mar; 18(1):21. PubMed ID: 38502412
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
    Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
    Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evolutionary dynamics of tipifarnib in hras mutated head and neck squamous cell carcinoma.
    Jagadeeshan S; Suryamohan K; Shin N; Mathukkada S; Boyko A; Melikhova D; Tsareva A; Yunusova L; Pravdivtseva E; Stupichev D; Shaposhnikov K; Peterson A; Bednyagin L; Shugaev-Mendosa E; Kessler L; Burrows F; Ho AL; Agrawal N; Pearson AT; Izumchenko E; Cole G; Elkabets M; Rosenberg AJ
    Oral Oncol; 2024 Feb; 149():106688. PubMed ID: 38219706
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and hras Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
    Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
    Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
    Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary Thyroid cancer.
    Amanullah M; Pan M; Lu K; Pan X; Lu Y; Luo D; Liu P
    Curr Oncol; 2023 Feb; 30(3):2625-2641. PubMed ID: 36975413
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?
    Ben Yahia H; Petit FM; Saada-Bouzid E
    Curr Opin Oncol; 2023 May; 35(3):178-185. PubMed ID: 36966498
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program.
    Doerstling S; Winski D; Katsoulakis E; Agarwal P; Poonnen PJ; Snowdon JL; Jackson GP; Weeraratne D; Kelley MJ; Vashistha V
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):69-77. PubMed ID: 36117189
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unraveling molecular mechanisms of head and neck cancer.
    Antra ; Parashar P; Hungyo H; Jain A; Ahmad S; Tandon V
    Crit Rev Oncol Hematol; 2022 Oct; 178():103778. PubMed ID: 35932993
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.
    Guo Y; Zhang L; Zhang N; Chen L; Luo Q; Liu M; Yang D; Chen J
    Endocrine; 2022 Oct; 78(1):159-168. PubMed ID: 35895181
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeting IL-1β as an immunopreventive and therapeutic modality for k-ras-mutant lung cancer.
    Yuan B; Clowers MJ; Velasco WV; Peng S; Peng Q; Shi Y; Ramos-Castaneda M; Zarghooni M; Yang S; Babcock RL; Chang SH; Heymach JV; Zhang J; Ostrin EJ; Watowich SS; Kadara H; Moghaddam SJ
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35471938
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the Thyroid and Advances in Management.
    Nguyen M; He G; Lam AK
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
    Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
    Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
    Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
    J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating hras via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.